1.
Int J Biol Markers
; 15(3): 235-6, 2000.
Article
in English
| MEDLINE
| ID: mdl-11012100
ABSTRACT
Hypoxic tumors of patients with squamous cell carcinoma of the head and neck show a consistent trend towards poor treatment outcome. We now report that tumor hypoxia in these patients is correlated with elevated antigen content of the tumor-associated serine protease uPA (urokinase-type plasminogen activator), a marker of tumor cell invasion and metastasis.